[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (63)

Search Parameters:
Keywords = IDU

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 3258 KiB  
Review
Endoscopic Ultrasound and Intraductal Ultrasound in the Diagnosis of Biliary Tract Diseases: A Narrative Review
by Akiya Nakahata, Yasunobu Yamashita and Masayuki Kitano
Diagnostics 2024, 14(18), 2086; https://doi.org/10.3390/diagnostics14182086 - 20 Sep 2024
Viewed by 586
Abstract
Endoscopic ultrasound (EUS) and intraductal ultrasound (IDUS) play very important roles in the field of biliary tract disease. Because of their excellent spatial resolution, the detection of small lesions and T- or N-staging of tumors have become possible. Additionally, contrast-enhanced EUS and the [...] Read more.
Endoscopic ultrasound (EUS) and intraductal ultrasound (IDUS) play very important roles in the field of biliary tract disease. Because of their excellent spatial resolution, the detection of small lesions and T- or N-staging of tumors have become possible. Additionally, contrast-enhanced EUS and the new imaging technique of detective flow imaging are reported to be useful for differential diagnosis. Furthermore, EUS-guided tissue acquisition is used not only for pathological diagnosis but also to collect tissue samples for cancer genome profiling. This review provides an overview of diagnosis utilizing the features and techniques of EUS and IDUS. Full article
Show Figures

Figure 1

Figure 1
<p>Images and schema of the two types of endoscopic ultrasound (EUS). (<b>a</b>) Convex-type EUS (GF-UCT260, Olympus, Tokyo, Japan); (<b>b</b>) radial-type EUS (GF-UE290, Olympus, Japan); (<b>c</b>) scheme of convex-type EUS; (<b>d</b>) scheme of radial type EUS; (<b>e</b>) ultrasound view of convex-type EUS; and (<b>f</b>) ultrasound view of radial-type EUS.</p>
Full article ">Figure 2
<p>These are images of intraductal ultrasound probes: (<b>a</b>,<b>b</b>) the ultrasound probe is attached at the point indicated by the red arrow (UM-DG20-31R, Olympus, Japan).</p>
Full article ">Figure 3
<p>Detection of small choledocholithiasis by intraductal ultrasound (IDUS) and endoscopic ultrasound (EUS): (<b>a</b>) IDUS image of choledocholithiasis (arrowhead, 5 mm); (<b>b</b>) EUS image of choledocholithiasis (arrowhead, 5 mm).</p>
Full article ">Figure 4
<p>Images of the normal structure of the biliary duct wall and gallbladder wall: (<b>a</b>,<b>b</b>) images of the biliary duct wall on intraductal ultrasound and the gallbladder wall on endoscopic ultrasound; (<b>c</b>,<b>d</b>) red arrows show the inner hypoechoic layer corresponding to the mucosa, the muscularis propria, and part of the subserosa. Yellow arrows show the outer hyperechoic layer corresponding to part of the subserosa and the serosa.</p>
Full article ">Figure 5
<p>Endoscopic ultrasound image of adenomyomatosis: thickened wall and cystic anechoic spots are visible. The cystic spots show Rokitansky–Aschoff sinuses.</p>
Full article ">Figure 6
<p>Pancreaticobiliary maljunction: an endoscopic ultrasound image showing the pancreatic duct and the bile duct converging outside the duodenal wall.</p>
Full article ">
16 pages, 1614 KiB  
Article
HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania
by Camelia Sultana, Carmine Falanga, Grațiana Chicin, Laurențiu Ion, Camelia Grancea, Daniela Chiriac, Adriana Iliescu and Andrea Gori
Viruses 2024, 16(8), 1279; https://doi.org/10.3390/v16081279 - 10 Aug 2024
Viewed by 858
Abstract
The objective of this study was to analyze the epidemiological links of the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and HIV-HCV coinfections to less studied types of transmission in certain populations. We performed an observational, prospective study on 903 patients aged [...] Read more.
The objective of this study was to analyze the epidemiological links of the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and HIV-HCV coinfections to less studied types of transmission in certain populations. We performed an observational, prospective study on 903 patients aged between 15–87 years who took part in the Open Test Project. They were divided in two subgroups: general population vs. individuals from prisons who were questioned about multiple risk factors. A chi-square independence test was used to establish correlations between risk factors and results of screening tests. Logistic regression was used to calculate the probability of a reactive screening test based on each independent risk factor and age. HIV was very strongly associated with unprotected sexual intercourse with HIV-positive partners (the strongest association), unprotected sexual intercourse with sex workers, newly diagnosed sexually transmitted diseases (STDs), intravenous drug users (IDUs) and sharing injecting materials. In the case of HCV reactive tests, very strong associations have been established with IDUs (the strongest association), unprotected sex with IDUs and sharing injecting materials. Our study indicates the need for implementing targeted public health programs, tailored to the local epidemiology that can ultimately lead to micro-elimination of hepatitis and HIV infections in this area. Full article
(This article belongs to the Special Issue HIV and HTLV Infections and Coinfections)
Show Figures

Figure 1

Figure 1
<p>Variation in the probability of obtaining positive HIV and HCV screening tests or the presence of HIV-HCV coinfection based on the presence of the risk factor (intravenous drug users) among individuals in the general population and in the inmate population: (<b>a</b>) graphical representation of how the probability of a positive HIV screening test varies based on the presence or absence of the risk factor among individuals of the same age in the general population; (<b>b</b>) HCV in the general population; (<b>c</b>) HIV-HCV coinfection in the general population; (<b>d</b>) graphical representation of how the probability of a positive HIV screening test varies based on the presence or absence of the risk factor among individuals of the same age in the inmate population; (<b>e</b>) HCV in the inmate population; (<b>f</b>) HIV-HCV coinfection in the inmate population.</p>
Full article ">Figure 2
<p>Variation in the probability of obtaining positive HIV and HCV screening tests or the presence of HIV-HCV coinfection based on the presence of the risk factor (sharing injection materials such as syringes and needles within the last 12 months) among individuals in the general population and in the inmate population: (<b>a</b>) graphical representation of how the probability of a positive HIV screening test varies based on the presence or absence of the risk factor among individuals of the same age in the general population; (<b>b</b>) HCV in the general population; (<b>c</b>) HIV-HCV coinfection in the general population; (<b>d</b>) graphical representation of how the probability of a positive HIV screening test varies based on the presence or absence of the risk factor among individuals of the same age in the inmate population; (<b>e</b>) HCV in the inmate population; (<b>f</b>) HIV-HCV coinfection in the inmate population.</p>
Full article ">Figure 3
<p>Variation in the probability of obtaining positive HIV and HCV screening tests or the presence of HIV-HCV coinfection based on the presence of the risk factor (unprotected sexual intercourse with intravenous drug users in the past 12 months) among individuals in the general population and in the inmate population: (<b>a</b>) graphical representation of how the probability of a positive HIV screening test varies based on the presence or absence of the risk factor among individuals of the same age in the general population; (<b>b</b>) HCV in the general population; (<b>c</b>) HIV-HCV coinfection in the general population; (<b>d</b>) graphical representation of how the probability of a positive HIV screening test varies based on the presence or absence of the risk factor among individuals of the same age in the inmate population; (<b>e</b>) HCV in the inmate population; (<b>f</b>) HIV-HCV coinfection in the inmate population.</p>
Full article ">Figure 4
<p>Established associations between risk factors and the results of the screening tests for HIV, HCV and coinfection in the general population and inmate population based on the phi coefficient and Cramer’s V coefficient.</p>
Full article ">
13 pages, 246 KiB  
Article
Polysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment
by Lindsey R. Riback, Mercy Nyakowa, John A. Lizcano, Chenshu Zhang, Peter Cherutich, Ann E. Kurth and Matthew J. Akiyama
Viruses 2024, 16(8), 1277; https://doi.org/10.3390/v16081277 - 10 Aug 2024
Viewed by 694
Abstract
Polysubstance use (PSU), injection drug use (IDU), and equipment sharing are associated with bloodborne infection (BBI) transmission risk, particularly Hepatitis C Virus (HCV), yet data on PSU in low- and middle-income countries (LMICs) is limited. We report on baseline PSU, medication-assisted treatment (MAT) [...] Read more.
Polysubstance use (PSU), injection drug use (IDU), and equipment sharing are associated with bloodborne infection (BBI) transmission risk, particularly Hepatitis C Virus (HCV), yet data on PSU in low- and middle-income countries (LMICs) is limited. We report on baseline PSU, medication-assisted treatment (MAT) engagement, and motivation to reduce IDU among 95 people who inject drugs (PWID) who accessed needle and syringe programs (NSP) in Nairobi and Coastal Kenya prior to HCV treatment. Bivariate and multivariate logistic regression were used to examine the associations between PSU and behaviors that confer HCV transmission and acquisition risks. Most participants (70.5%) reported PSU in the last 30 days, and one-third (35.8%) reported PSU exclusive to just heroin and cannabis use. Common combinations were heroin and cannabis (49.3%), and heroin, cannabis, and bugizi (flunitrazepam) (29.9%). Participants at baseline were receiving MAT (69.5%), already stopped or reduced IDU (30.5%), and were HIV-positive (40%). PSU was significantly associated with IDU (p = 0.008) and the number of times (p = 0.016) and days (p = 0.007) injected in the last 30 days. Participants reported high PSU and equipment sharing, despite high MAT engagement. While co-locating BBI treatment within existing harm reduction services is necessary to promote uptake and curb re-infection, tailored services may be needed to address PSU, particularly in LMICs. Full article
(This article belongs to the Special Issue Hepatitis C Virus Infection among People Who Inject Drugs)
13 pages, 2858 KiB  
Article
Risk Factors Associated with Hepatitis C Subtypes and the Evolutionary History of Subtype 1a in Mexico
by Saul Laguna-Meraz, Alexis Jose-Abrego, Sonia Roman, Leonardo Leal-Mercado and Arturo Panduro
Viruses 2024, 16(8), 1259; https://doi.org/10.3390/v16081259 - 6 Aug 2024
Cited by 1 | Viewed by 912
Abstract
The Hepatitis C Virus (HCV), with its diverse genotypes and subtypes, has significantly impacted the health of millions of people worldwide. Analyzing the risk factors is essential to understanding the spread of the disease and developing appropriate prevention strategies. This study aimed to [...] Read more.
The Hepatitis C Virus (HCV), with its diverse genotypes and subtypes, has significantly impacted the health of millions of people worldwide. Analyzing the risk factors is essential to understanding the spread of the disease and developing appropriate prevention strategies. This study aimed to identify risk factors associated with HCV subtype transmission and calculate the emergence time of subtype 1a in Mexico. A cross-sectional study was conducted from January 2014 to December 2018, involving 260 HCV-infected adults. HCV infection was confirmed via Enzyme-Linked Immunosorbent Assay, and viral load was measured by real-time PCR. Genotyping/subtyping tools were the Line Probe Assay and Sanger sequencing of the non-structural region 5B (NS5B). The most frequent HCV subtype was 1a (58.5%), followed by subtypes 1b (19.2%), 3a (13.1%), 2b (5.4%), 2a/2c (2.7%), 2a (0.8%), and 4a (0.4%). Intravenous drug use and tattoos were significant risk factors for subtypes 1a and 3a, while hemodialysis and blood transfusion were linked with subtype 1b. For the evolutionary analysis, 73 high-quality DNA sequences of the HCV subtype 1a NS5B region were used, employing a Bayesian coalescent analysis approach. This analysis suggested that subtype 1a was introduced to Mexico in 1976, followed by a diversification event in the mid-1980s. An exponential increase in cases was observed from 1998 to 2006, stabilizing by 2014. In conclusion, this study found that HCV subtypes follow distinct transmission routes, emphasizing the need for targeted prevention strategies. Additionally, the findings provide valuable insights into the origin of HCV subtype 1a. By analyzing the history, risk factors, and dynamics of the HCV epidemic, we have identified these measures: limiting the harm of intravenous drug trafficking, enhancing medical training and infrastructure, and ensuring universal access to antiviral treatments. The successful implementation of these strategies could lead to an HCV-free future in Mexico. Full article
(This article belongs to the Section Human Virology and Viral Diseases)
Show Figures

Figure 1

Figure 1
<p>Sample collection strategy for studying risk factors, HCV subtypes, and the evolutionary analysis of HCV subtype 1a in Mexico.</p>
Full article ">Figure 2
<p>General distribution of HCV subtypes (<b>A</b>) and their frequency by risk factor (<b>B</b>). IDUs: Injection drug use.</p>
Full article ">Figure 3
<p>Univariate analysis was conducted to identify risk factors associated with HCV subtypes 1a (<b>A</b>), 1b (<b>B</b>), 2 (<b>C</b>), and 3a (<b>D</b>). IDUs: Injection drug users. The dots represent the Odds Ratio, and the bars indicate the 95% confidence interval.</p>
Full article ">Figure 4
<p>(<b>A</b>) The phylogenetic tree illustrates the evolutionary history of HCV subtype 1a infections in Mexico. The time to the most recent common ancestor (TMRCA) of HCV subtype 1a is at the tree’s base. The length of each branch represents the time elapsed from the root to the present. (<b>B</b>) Reconstruction of the HCV subtype 1a epidemic in Mexico from 1976 to 2014. The orange dots indicate the median estimated number of infections per year, and the gray shaded area represents the 95% highest posterior density interval. The purple rectangle highlights a phase of increasing HCV subtype 1a infections. (<b>C</b>) Graph showing the documented cases of HCV infections in Mexico from 2001 to 2019. The red dots indicate the number of infections per year, the orange line shows the trend, and the shade indicates the confidence interval of the trend line. These data were collected from Mexico’s Annual Morbidity Reports. Available at: <a href="http://epidemiologia.salud.gob.mx" target="_blank">http://epidemiologia.salud.gob.mx</a>, consulted on 16 June 2024.</p>
Full article ">
11 pages, 2127 KiB  
Article
Endoscopic Retrograde Cholangiopancreatography-Related Procedures for the Differential Diagnosis of Isolated Immunoglobin G4-Related Sclerosing Cholangitis and Perihilar Cholangiocarcinoma
by Masaru Furukawa, Yasutaka Ishii, Yumiko Tatsukawa, Shinya Nakamura, Juri Ikemoto, Sayaka Miyamoto, Kazuki Nakamura, Yumiko Yamashita, Noriaki Iijima, Yasuhiro Okuda, Risa Nomura, Koji Arihiro, Keiji Hanada and Shiro Oka
Diagnostics 2024, 14(15), 1621; https://doi.org/10.3390/diagnostics14151621 - 26 Jul 2024
Viewed by 665
Abstract
Background/Purpose: Differential diagnosis of isolated immunoglobin (Ig)G4-related sclerosing cholangitis (IgG4-SC) and cholangiocarcinoma is challenging. We aimed to clarify the role of endoscopic retrograde cholangiography (ERCP)-related procedures in the differential diagnosis of isolated IgG4-SC and perihilar cholangiocarcinoma (PHCC). Methods: Seven patients with hilar-type isolated [...] Read more.
Background/Purpose: Differential diagnosis of isolated immunoglobin (Ig)G4-related sclerosing cholangitis (IgG4-SC) and cholangiocarcinoma is challenging. We aimed to clarify the role of endoscopic retrograde cholangiography (ERCP)-related procedures in the differential diagnosis of isolated IgG4-SC and perihilar cholangiocarcinoma (PHCC). Methods: Seven patients with hilar-type isolated IgG4-SC diagnosed at Hiroshima University Hospital and sixty-five patients with surgically resected invasive PHCC were enrolled, and the diagnostic yields of intraductal ultrasonography (IDUS), peroral cholangioscopy (POCS), and pathological examinations were determined. Results: In six of seven (86%) patients with isolated IgG4-SC, the stricture was in the perihilar bile duct. IDUS showed that symmetrical wall thickening (40% vs. 5%, p = 0.04), homogeneous internal echo (80% vs. 5%, p < 0.001), and smooth outer margins (80% vs. 6%, p < 0.001) were more frequent in isolated IgG4-SC than in PHCC. POCS showed a smooth mucosal surface more frequent in isolated IgG4-SC (75% vs. 7%, p = 0.006). Only one patient had two pathological findings characteristic of IgG4-SC. The sensitivity for diagnosing PHCC was 81% using two or more combined sampling methods. Conclusions: Pathological examinations have limitations in the differential diagnosis of isolated-IgG4-SC and PHCC, and a diagnostic strategy that combines multiple ERCP-related procedures, including IDUS and POCS, is recommended. Full article
Show Figures

Figure 1

Figure 1
<p>Breakdown of the patients diagnosed with IgG4-SC. Forty-one patients were diagnosed with IgG4-SC and AIP, and seven patients were diagnosed with isolated IgG4-SC. Among patients with isolated IgG4-SC, one patient had a type 2 biliary stricture and six patients had a type 4 biliary stricture. AIP, autoimmune pancreatitis; IgG4-SC, IgG4 related sclerosing cholangitis.</p>
Full article ">Figure 2
<p>Images of the patients with isolated IgG4-related sclerosing cholangitis. (<b>a</b>,<b>b</b>) Contrast-enhanced computed tomography images. Bile duct stricture and wall thickness in the perihilar region of the bile duct. The pancreas is normal, without findings of autoimmune pancreatitis. (<b>c</b>) Cholangiographic image. Stricture in the perihilar region of the bile duct. (<b>d</b>) Pancreatographic image. Normal pancreatic duct. (<b>e</b>) Intraductal ultrasonographic image of the stricture site. Wall thickness of bile duct was asymmetrical, internal echo was homogeneous, and lateral margin of bile duct was smooth. (<b>f</b>) Intraductal ultrasonographic image outside the stricture site. Symmetrical wall thickness of bile duct. (<b>g</b>) Cholangioscopic image in the stricture site. Mucosal surface was regular, and irregular vessels were absent. (<b>h</b>) Hematoxylin-Eosin stain (original magnification: ×800). Lymphocytic and plasmacyte infiltration and fibrosis detected by forceps biopsy of the stricture site. (<b>i</b>) IgG4-positive plasma cells detected by forceps biopsy of the stricture site (original magnification: ×800).</p>
Full article ">
16 pages, 2959 KiB  
Article
Novel Collagen Membrane Formulations with Irinotecan or Minocycline for Potential Application in Brain Cancer
by Andreea-Anamaria Idu, Mădălina Georgiana Albu Kaya, Ileana Rău, Nicoleta Radu, Cristina-Elena Dinu-Pîrvu and Mihaela Violeta Ghica
Materials 2024, 17(14), 3510; https://doi.org/10.3390/ma17143510 - 15 Jul 2024
Viewed by 780
Abstract
Our study explores the development of collagen membranes with integrated minocycline or irinotecan, targeting applications in tissue engineering and drug delivery systems. Type I collagen, extracted from bovine skin using advanced fibril-forming technology, was crosslinked with glutaraldehyde to create membranes. These membranes incorporated [...] Read more.
Our study explores the development of collagen membranes with integrated minocycline or irinotecan, targeting applications in tissue engineering and drug delivery systems. Type I collagen, extracted from bovine skin using advanced fibril-forming technology, was crosslinked with glutaraldehyde to create membranes. These membranes incorporated minocycline, an antibiotic, or irinotecan, a chemotherapeutic agent, in various concentrations. The membranes, varying in drug concentration, were studied by water absorption and enzymatic degradation tests, demonstrating a degree of permeability. We emphasize the advantages of local drug delivery for treating high-grade gliomas, highlighting the targeted approach’s efficacy in reducing systemic adverse effects and enhancing drug bioavailability at the tumor site. The utilization of collagen membranes is proposed as a viable method for local drug delivery. Irinotecan’s mechanism, a topoisomerase I inhibitor, and minocycline’s broad antibacterial spectrum and inhibition of glial cell-induced membrane degradation are discussed. We critically examine the challenges posed by the systemic administration of chemotherapeutic agents, mainly due to the blood–brain barrier’s restrictive nature, advocating for local delivery methods as a more effective alternative for glioblastoma treatment. These local delivery strategies, including collagen membranes, are posited as significant advancements in enhancing therapeutic outcomes for glioblastoma patients. Full article
Show Figures

Figure 1

Figure 1
<p>Collagen membranes with minocycline 40% (<b>a</b>) and irinotecan 10% (<b>b</b>).</p>
Full article ">Figure 2
<p>Water absorption for collagen membranes with different concentrations of minocycline. A <span class="html-italic">p</span>-value &gt; 0.5 indicates that the results obtained are not statistically significant. “*” corresponds to results with statistical significance (0.5 &lt; <span class="html-italic">p</span> &lt; 0.1), “**” corresponds to distinctly statistically significant results (0.1 ≤ <span class="html-italic">p</span> &lt; 0.01), and “***” corresponds to highly statistically significant results (<span class="html-italic">p</span> ≤ 0.01).</p>
Full article ">Figure 3
<p>Water absorption for the collagen-based membranes with different irinotecan concentrations. A <span class="html-italic">p</span>-value &gt; 0.5 indicates that the results obtained are not statistically significant. “*” corresponds to results with statistical significance (0.5 &lt; <span class="html-italic">p</span> &lt; 0.1), “**” corresponds to distinctly statistically significant results (0.1 ≤ <span class="html-italic">p</span> &lt; 0.01), and “***” corresponds to highly statistically significant results (<span class="html-italic">p</span> ≤ 0.01).</p>
Full article ">Figure 4
<p>Collagenase degradation of collagen membranes with minocycline. A <span class="html-italic">p</span>-value &gt; 0.5 indicates that the results obtained are not statistically significant. “*” corresponds to results with statistical significance (0.5 &lt; <span class="html-italic">p</span> &lt; 0.1), “**” corresponds to distinctly statistically significant results (0.1 ≤ <span class="html-italic">p</span> &lt; 0.01), and “***” corresponds to highly statistically significant results (<span class="html-italic">p</span> ≤ 0.01).</p>
Full article ">Figure 5
<p>Collagenase degradation of the collagen membranes with irinotecan. A <span class="html-italic">p</span>-value &gt; 0.5 indicates that the results obtained are not statistically significant. “*” corresponds to results with statistical significance (0.5 &lt; <span class="html-italic">p</span> &lt; 0.1), “**” corresponds to distinctly statistically significant results (0.1 ≤ <span class="html-italic">p</span> &lt; 0.01), and “***” corresponds to highly statistically significant results (<span class="html-italic">p</span> ≤ 0.01).</p>
Full article ">Figure 6
<p>Antibacterial effects of minocycline. (<b>a</b>) Test performed on thin biofilm; (<b>b</b>) minimal inhibitory concentration of minocycline on <span class="html-italic">S. aureus</span>, for different applied standards (data adapted after Bidell et al., 2021 [<a href="#B44-materials-17-03510" class="html-bibr">44</a>]); (<b>c</b>) effect of minocycline 5 mg/mL on <span class="html-italic">E. coli</span>; (<b>d</b>) effect of thin film M1 on <span class="html-italic">E. coli</span>; (<b>e</b>) effect of minocycline 5 mg/mL on <span class="html-italic">S. aureus</span>; (<b>f</b>) effect of thin film M1 on <span class="html-italic">S. aureus</span>; (<b>g</b>) effect of thin film IR4 with irinotecan on <span class="html-italic">E. coli</span>; (<b>h</b>) effect of thin film IR3 with irinotecan on <span class="html-italic">E. coli</span>; (<b>i</b>) effect of thin film IR1 with irinotecan on <span class="html-italic">E. coli</span>. n.d. = not determined; CLSI = Clinical and Laboratory Standard Institute; EUCAST = European Committee on Antimicrobial Susceptibility; FDA = Food and Drug Administration, USA.</p>
Full article ">Figure 7
<p>Time-dependent cumulative release patterns of minocycline from collagen membranes.</p>
Full article ">Figure 8
<p>Time-dependent cumulative release patterns of irinotecan from collagen membranes.</p>
Full article ">
13 pages, 2552 KiB  
Article
Stoichiometric Homeostasis of N and P in the Leaves of Different-Aged Phyllostachys edulis after Bamboo Forest Expansion in Subtropical China
by Jingxin Shen, Shaohui Fan, Jiapeng Zhang and Guanglu Liu
Forests 2024, 15(7), 1181; https://doi.org/10.3390/f15071181 - 8 Jul 2024
Viewed by 591
Abstract
Stoichiometric homeostasis is an important mechanism in maintaining ecosystem structure, function, and stability. Phyllostachys edulis (moso bamboo) is a typical clone plant, forming pure bamboo forests or bamboo–wood mixed forests by expanding rhizomes around. Studying the stoichiometric homeostasis characteristics of moso bamboo at [...] Read more.
Stoichiometric homeostasis is an important mechanism in maintaining ecosystem structure, function, and stability. Phyllostachys edulis (moso bamboo) is a typical clone plant, forming pure bamboo forests or bamboo–wood mixed forests by expanding rhizomes around. Studying the stoichiometric homeostasis characteristics of moso bamboo at different ages after expansion contributes to a deeper understanding of the stability of bamboo forest ecosystems, and is of great significance for expanding the research scope of ecological stoichiometry. Based on the stoichiometric internal stability theory, the nitrogen (N) and phosphorus (P) elements in the soil and plants of typical moso bamboo forests in Tianbaoyan National Nature Reserve of Fujian Province were determined, and the internal stability index (H) of bamboo leaves of different ages (I-du, II-du, III-du, and IV-du bamboos) was calculated. The results showed that the dependence of moso bamboo on soil nutrients and the ability of moso bamboo to regulate nutrient elements were both significantly affected by the plant’s age. Under the condition of the same soil nutrients (N, P), the content of N and P in bamboo leaves decreased significantly with the increase in bamboo age. The limiting effect of phosphorus on the growth and development of moso bamboo was greater than that of nitrogen, and the limiting effect of phosphorus on aged bamboo was greater than that of young bamboo. The stoichiometric internal stability index of N and P in bamboo leaves is HN:P > HN > HP, which means that the internal stability of moso bamboo is closely related to the limiting elements. Therefore, the regulation ability of the internal stability of moso bamboo of different ages makes it grow well in the changeable environment, has stronger adaptability and competitiveness, and the leaf internal stability of I-du bamboo was higher than that of other ages, which may be one of the reasons for its successful expansion to form a stable bamboo stand structure. Full article
Show Figures

Figure 1

Figure 1
<p>Location of the study area and the layout of the experimental plots.</p>
Full article ">Figure 2
<p>Leaf N (<b>a</b>), P (<b>b</b>), N:P (<b>c</b>), and their coefficient in variation (CV) (<b>d</b>) of different-aged moso bamboo. I, II, III, and IV represent 1, 2–3, 4–5, and &gt;6 years, respectively. Different lowercase letters indicate significant differences among the means of the different ages (at the <span class="html-italic">p</span> &lt; 0.05 level).</p>
Full article ">Figure 3
<p>Nitrogen (N), phosphorus (P), available nitrogen (HN), and available phosphorus (AP) content and N:P ratio in the soil of Moso bamboo at different ages. I, II, III, and IV represent 1, 2–3, 4–5, and &gt;6 years. (<b>a</b>–<b>f</b>) respectively represent soil organic carbon content, soil nitrogen (N) content, soil phosphorus (P) content, soil available nitrogen (HN) content, soil available phosphorus (AP) content, and the soil nitrogen to phosphorus ratio (N:P).</p>
Full article ">Figure 4
<p>The correlation coefficients between soil and plants in their nitrogen (N) and phosphorus (P) concentrations. Red represents a positive correlation and green represents a negative correlation. * Indicates a significant correlation at the <span class="html-italic">p</span> &lt; 0.05 level; ** indicates a significant correlation at the <span class="html-italic">p</span> &lt; 0.01 level.</p>
Full article ">Figure 5
<p>The homeostatic index (<span class="html-italic">H</span>) of N, P, and N:P values of Moso bamboo leaves. (<b>a</b>–<b>c</b>) Represent the fitting relationship between soil N, P, N/P ratio and N, P, N/P ratio of bamboo leaves. (<b>d</b>) represents the H values of N, P and N:P ratio of moso bamboo leaves. The pink area is the fitting function and its confidence interval values. The solid red line shows the fit of the homeostatic index of Moso bamboo leaves.</p>
Full article ">Figure 6
<p>Fitting of the nutrient content of bamboo leaves at different ages to soil nutrient content. The pink area is the fitting function and its confidence interval values. The solid red line shows the fit of the homeostatic index of moso bamboo leaves. I, II, III, and IV represent 1, 2–3, 4–5, and &gt;6 years. (<b>a</b>–<b>l</b>) Represent the fitting relationship between soil N, P, N/P ratio and N, P, N/P ratio of bam-boo leaves.</p>
Full article ">Figure 7
<p>The homeostatic index (<span class="html-italic">H</span>) for different element and ages. I, II, III, and IV represent 1, 2–3, 4–5, and &gt;6 years. The ‘–‘ above column diagrams denotes <span class="html-italic">H</span> values &lt; 0. (<b>a</b>) different element (<b>b</b>) different ages.</p>
Full article ">
11 pages, 2438 KiB  
Article
Positive Effects of Guanidinium Salt Post-Treatment on Multi-Cation Mixed Halide Perovskite Solar Cells
by Damir Aidarkhanov, Ikenna Henry Idu, Xianfang Zhou, Dawei Duan, Fei Wang, Hanlin Hu and Annie Ng
Nanomaterials 2024, 14(13), 1161; https://doi.org/10.3390/nano14131161 - 7 Jul 2024
Viewed by 977
Abstract
As one of the most promising photovoltaic technologies, perovskite solar cells (PSCs) exhibit high absorption coefficients, tunable bandgaps, large carrier mobilities, and versatile fabrication techniques. Nevertheless, the commercialization of the technology is hindered by poor material stability, short device lifetimes and the scalability [...] Read more.
As one of the most promising photovoltaic technologies, perovskite solar cells (PSCs) exhibit high absorption coefficients, tunable bandgaps, large carrier mobilities, and versatile fabrication techniques. Nevertheless, the commercialization of the technology is hindered by poor material stability, short device lifetimes and the scalability of fabrication techniques. To address these technological drawbacks, various strategies have been explored, with one particularly promising approach involving the formation of a low-dimensional layer on the surface of the three-dimensional perovskite film. In this work, we demonstrate the use of guanidinium tetrafluoroborate, CH6BF4N3, (GATFB) as a post-treatment step to enhance the performance of PSCs. Compared with the control sample, the application of GATFB improves the film surface topology, reduces surface defects, suppresses non-radiative recombination, and optimizes band alignment within the device. These positive effects reduce recombination losses and enhance charge transport in the device, resulting in PSCs with an open-circuit voltage (VOC) of 1.18 V and a power conversion efficiency (PCE) of 19.7%. The results obtained in this work exhibit the potential of integrating low-dimensional structures in PSCs as an effective approach to enhance the overall device performance, providing useful information for further advancement in this rapidly evolving field of photovoltaic technology. Full article
(This article belongs to the Section Solar Energy and Solar Cells)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) XPS spectra of F 1s peak for the control and GATFB-treated perovskite films; the structural formula of GATFB is shown in the inset; (<b>b</b>) XPS spectra of B 1s peak for pristine and GATFB-treated perovskite films; (<b>c</b>) UPS spectra of untreated and GATFB-treated perovskite films; (<b>d</b>) the energy band diagram of the functional layers in a complete device.</p>
Full article ">Figure 2
<p>The SEM top-view and cross-section (inset) images of the (<b>a</b>) control and (<b>b</b>) GATFB-treated perovskite films; AFM topology images of (<b>c</b>) control and (<b>d</b>) GATFB-treated perovskite films; conductive probe AFM topology images of (<b>e</b>) control and (<b>f</b>) GATFB-treated perovskite films.</p>
Full article ">Figure 3
<p>(<b>a</b>) XRD spectra of the control and GATFB-treated films. Inserts demonstrate enlarged (110) and (220) plane peaks; (<b>b</b>) GIWAXS patterns of perovskite films treated with different concentrations of GATFB.</p>
Full article ">Figure 4
<p>(<b>a</b>) Absorbance spectra of the control and GATFB-treated perovskite films; (<b>b</b>) PL spectra of the control and GATFB-treated perovskite films; (<b>c</b>) TRPL spectra of the control and GATFB-treated perovskite films; (<b>d</b>) <span class="html-italic">JV</span>-curve of best-performing device and main device parameters; (<b>e</b>) EQE and integrated <span class="html-italic">J<sub>SC</sub></span> for the control and GATFB-treated devices; (<b>f</b>) <span class="html-italic">J<sub>SC</sub></span> dependence on light intensity in logarithmic scale for untreated and GATFB-treated devices; (<b>g</b>) <span class="html-italic">V<sub>OC</sub></span> dependence on light intensity in semi-logarithmic scale for the control and GATFB-treated devices.</p>
Full article ">
7 pages, 216 KiB  
Perspective
Even Though the System Had Failed Him His Entire Life, We Were Failing Him Yet Again”: How Clinical, Welfare, and Penal Medicine Interact to Drive Health Inequities and Medical Moral Injury
by Siddhi S. Ganesh, Kyle B. Joyner, Shamsher Samra, Ricky N. Bluthenthal and Todd W. Schneberk
Healthcare 2024, 12(13), 1354; https://doi.org/10.3390/healthcare12131354 - 7 Jul 2024
Viewed by 997
Abstract
Adam, a justice-involved young man, was brought into the emergency department at the county hospital in cardiogenic shock due to a recurring episode of injection-drug-use-related infective endocarditis (IDU-IE). Adam had initiated injection opioid use in prison. He was surgically treated for the previous [...] Read more.
Adam, a justice-involved young man, was brought into the emergency department at the county hospital in cardiogenic shock due to a recurring episode of injection-drug-use-related infective endocarditis (IDU-IE). Adam had initiated injection opioid use in prison. He was surgically treated for the previous episodes of IDU-IE but was unable to fully recover due to limitations in care within penal medicine. This case report explores the prison as a determinant of health, interactions between clinical, welfare, and penal medicine, to produce and maintain health inequities, and structural drivers of physician moral injury through an interview with Adam and reflexive writings from emergency medicine physicians. This case demonstrates the need for three types of structural health interventions: (1) restorative justice, community-based reentry programs, and housing as welfare medicine, (2) increased harm reduction services across healthcare, especially penal medicine, and (3) equitable institutional protocols (contrary to ambiguous guidelines) to treat clinical conditions like IDU-IE that disproportionately impact structurally vulnerable patients. Full article
11 pages, 953 KiB  
Article
Direct Single-Operator Cholangioscopy and Intraductal Ultrasonography in Patients with Indeterminate Biliary Strictures: A Single Center Experience
by Marco Sacco, Marcantonio Gesualdo, Maria Teresa Staiano, Eleonora Dall’Amico, Stefania Caronna, Simone Dibitetto, Chiara Canalis, Alessandro Caneglias, Federica Mediati, Rosa Claudia Stasio, Silvia Gaia, Giorgio Maria Saracco, Mauro Bruno and Claudio Giovanni De Angelis
Diagnostics 2024, 14(13), 1316; https://doi.org/10.3390/diagnostics14131316 - 21 Jun 2024
Viewed by 735
Abstract
The evaluation of biliary strictures poses a challenge due to the low sensitivity of standard diagnostic approaches, but the advent of direct single-operator cholangioscopy (DSOC) has revolutionized this paradigm. Our study aimed to assess the diagnostic performance of DSOC and DSOC-targeted biopsies, intraductal [...] Read more.
The evaluation of biliary strictures poses a challenge due to the low sensitivity of standard diagnostic approaches, but the advent of direct single-operator cholangioscopy (DSOC) has revolutionized this paradigm. Our study aimed to assess the diagnostic performance of DSOC and DSOC-targeted biopsies, intraductal ultrasound (IDUS), and standard brush cytology in patients with indeterminate biliary strictures (IBS). We reviewed patients who underwent advanced diagnostic evaluation for IBS at our endoscopy unit from January 2018 to December 2022, all of whom had previously undergone at least one endoscopic attempt to characterize the biliary stricture. Final diagnoses were established based on surgical pathology and/or clinical and radiological follow-up spanning at least 12 months. A total of 57 patients, with a mean age of 67.2 ± 10.0 years, were included, with a mean follow-up of 18.2 ± 18.1 months. The majority of IBS were located in the distal common bile duct (45.6%), with malignancy confirmed in 35 patients (61.4%). DSOC and IDUS demonstrated significantly higher accuracies (89.5% and 82.7%, respectively) compared to standard cytology (61.5%, p < 0.05). Both DSOC visualization and IDUS exhibited optimal diagnostic yields in differentiating IBS with an acceptable safety profile. Full article
(This article belongs to the Special Issue Recent Advances and Challenges in Gastrointestinal Endoscopy)
Show Figures

Figure 1

Figure 1
<p>Cholangioscopic images of a malignant stricture with irregular mucosa and enlarged irregular vessels (<b>A</b>) and a benign stricture with smooth whitish biliary epithelium with fibrotic appearance (<b>B</b>).</p>
Full article ">Figure 2
<p>ROC curve of comparison between final diagnosis DSOC visual diagnosis (panel (<b>A</b>)), IDUS (panel (<b>B</b>)), DSOC-guided biopsies (panel (<b>C</b>)), and brush cytology (panel (<b>D</b>)).</p>
Full article ">
13 pages, 764 KiB  
Article
Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients
by Christine Roder, Carl Cosgrave, Kathryn Mackie, Bridgette McNamara, Joseph S. Doyle and Amanda J. Wade
Viruses 2024, 16(6), 979; https://doi.org/10.3390/v16060979 - 18 Jun 2024
Viewed by 1019
Abstract
Increasing testing is key to achieving hepatitis C elimination. This retrospective study aimed to assess the testing cascade of patients at a regional hospital in Victoria, Australia, who inject drugs or are living with hepatitis C, to identify missed opportunities for hepatitis C [...] Read more.
Increasing testing is key to achieving hepatitis C elimination. This retrospective study aimed to assess the testing cascade of patients at a regional hospital in Victoria, Australia, who inject drugs or are living with hepatitis C, to identify missed opportunities for hepatitis C care. Adult hospital inpatients and emergency department (ED) attendees from 2018 to 2021 with indications for intravenous drug use (IDU) or hepatitis C on their discharge or ED summary were included. Data sources: hospital admissions, pathology, hospital pharmacy, and outpatients. We assessed progression through the testing cascade and performed logistic regression analysis for predictors of hepatitis C care, including testing and treatment. Of 79,923 adults admitted, 1345 (1.7%) had IDU-coded separations and 628 (0.8%) had hepatitis C-coded separations (N = 1892). Hepatitis C virus (HCV) status at the end of the study was unknown for 1569 (82.9%). ED admissions were associated with increased odds of not providing hepatitis C care (odds ratio 3.29, 95% confidence interval 2.42–4.48). More than 2% of inpatients at our hospital have an indication for testing, however, most are not being tested despite their hospital contact. As we work toward HCV elimination in our region, we need to incorporate testing and linkage strategies within hospital departments with a higher prevalence of people at risk of infection. Full article
(This article belongs to the Special Issue Hepatitis C Virus Infection among People Who Inject Drugs)
Show Figures

Figure 1

Figure 1
<p>Cascade of care for patients with an indication of injecting-drug-use-related separations at University Hospital Geelong from 2018 to 2021. <span class="html-italic">n</span> = 1345 documented (measured and historical) positive test results for hepatitis C antibody, and RNA tests are shown in pink, with inferred positive tests shown in orange.</p>
Full article ">Figure 2
<p>Cascade of care for patients with hepatitis C-coded separations at University Hospital Geelong from 2018 to 2021. <span class="html-italic">n</span> = 628 documented (measured and historical) positive test results for hepatitis C antibody, and RNA tests are shown in pink, with inferred positive tests shown in orange.</p>
Full article ">
15 pages, 259 KiB  
Article
The Effects of the COVID-19 Pandemic on Healthcare Providers’ Mental Health: Experiences at Kenyatta National Hospital, Kenya
by Vallery Ogello, Nicholas Thuo, Phelix Okello, Njeri Wairimu, Paul Mwangi, Gakuo Maina, Harrison Mwenda, Paul Mutua, John Kinuthia, Linnet Ongeri, Nelly Mugo and Kenneth Ngure
Behav. Sci. 2024, 14(5), 351; https://doi.org/10.3390/bs14050351 - 23 Apr 2024
Viewed by 1244
Abstract
Background: In 2020, healthcare providers were expected to provide care to individuals with coronavirus disease 2019 (COVID-19), putting them at risk of acquiring COVID-19. The possibility of acquiring poorly understood infectious diseases while providing care may have an impact on the mental health [...] Read more.
Background: In 2020, healthcare providers were expected to provide care to individuals with coronavirus disease 2019 (COVID-19), putting them at risk of acquiring COVID-19. The possibility of acquiring poorly understood infectious diseases while providing care may have an impact on the mental health of providers. We conducted a study to explore the effects of COVID-19 on the mental health of healthcare providers. Methods: Between April and August 2021, we conducted in-depth interviews with 60 healthcare providers in the infectious disease unit (IDU) and other units of the hospital (non-IDU). The healthcare providers completed an online self-administered survey form with demographic data (age, sex, average income, and known contact with a COVID-19 patient). We used semi-structured interview guides to understand the healthcare providers’ lived experiences of stress, anxiety, depression, and their associated factors. We transcribed the interviews verbatim and coded and analyzed the transcripts to derive thematic concepts related to mental health experiences. Results: The healthcare providers had a median age of 37 years [IQR 20.0–58.0], and 56.7% were female, 30.0% nurses, 18.3% medical doctors, and 11.7% laboratory technologists. The healthcare providers reported increased stress during the pandemic, attributed to the high demand for patient care, changes in social life, and fear of COVID-19 infection. They also reported experiences of anxiety and depression as a result of limited knowledge at the beginning of the pandemic and the perception that “COVID-19 resulted in death”. Testing positive for COVID-19, high exposure to COVID-19 risks, and the death of patients and colleagues reportedly affected the healthcare providers’ mental health. Additionally, the healthcare providers reported mental health support through debriefing meetings, peer-to-peer support, and psychological counseling, with privacy and confidentiality concerns. Conclusions: Healthcare providers faced mental health issues such as stress and anxiety while taking care of COVID-19 patients. An effective mental health response requires institutional practices that address context-specific challenges such as privacy and confidentiality. Full article
(This article belongs to the Section Health Psychology)
18 pages, 3059 KiB  
Review
Sex, Age, and Risk Group Variations among Individuals Infected with HIV, HTLV-1, and HTLV-2: Review of Data Records (1983–2017) from a Public Health Laboratory in São Paulo, Brazil
by Adele Caterino-de-Araujo
Sexes 2023, 4(4), 638-655; https://doi.org/10.3390/sexes4040041 - 8 Dec 2023
Cited by 1 | Viewed by 1223
Abstract
The inaugural AIDS Program in Brazil was established in São Paulo in 1983, with the Instituto Adolfo Lutz appointed for laboratory assistance. Subsequently, research on HIV infections and HIV/HTLV (HIV/HTLV-1 and HIV/HTLV-2) co-infections was conducted. This narrative review focuses on studies from the [...] Read more.
The inaugural AIDS Program in Brazil was established in São Paulo in 1983, with the Instituto Adolfo Lutz appointed for laboratory assistance. Subsequently, research on HIV infections and HIV/HTLV (HIV/HTLV-1 and HIV/HTLV-2) co-infections was conducted. This narrative review focuses on studies from the Immunology Department (1983–2017) that significantly influenced AIDS diagnosis or provided epidemiological data such as prevalence rates, sex, age, and risk factors. Twelve studies, encompassing over 8000 individuals, are discussed. During 1983–1985, nearly all AIDS cases were attributed to homosexual/bisexual men aged 31 years old. Subsequently, heterosexual men and women emerged as risk groups owing to intravenous drug use (IDU) and/or unprotected sexual intercourse with AIDS patients or multiple partners per year. From 1985 onwards, vertical transmission led to child infections. HIV/HTLV co-infection rates decreased over time, initially associated with male IDU, and in the 2010s with female IDU, and individuals aged >40 years. Trends in HIV and HIV/HTLV co-infections among younger men and women (<30 years of age) were observed from 2015 to 2017. The changing characteristics and risk groups for HIV and HIV/HTLV co-infections over the years underscore the necessity for ongoing public policies to prevent retrovirus transmission, particularly among adolescents and young adults. Full article
(This article belongs to the Section Sexually Transmitted Infections/Diseases)
Show Figures

Figure 1

Figure 1
<p>In vitro induced antibody production (IVIAP) steps for detecting the production of specific antibodies by B lymphocytes in HIV-1-infected individuals.</p>
Full article ">Figure 2
<p>Distribution of the percentages of individuals infected with HIV-1 whose blood samples were sent to Instituto Adolfo Lutz, São Paulo, Brazil, for HTLV-1/-2 infection determination during 2010–2016, according to sex and age groups.</p>
Full article ">Figure 3
<p>Comparative analyses of the prevalence rates of HIV/HTLV-1/-2 and HIV/HTLV-1 and HIV/HTLV-2-co-infected individuals sampled from 1991 to 2015. The bars denote the prevalence rates determined by the number of individuals with HIV/HTLV co-infections (numbers above the bars) divided by the total number of individuals examined (numbers below the bars). The lines show the decline in HTLV prevalence rates. Differences that are statistically significant are depicted using the Chi-square test. <span class="html-italic">p</span>-values depicted as asterisks correspond to * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> ≤ 0.01; *** <span class="html-italic">p</span> ≤ 0.001, ns. not significant.</p>
Full article ">
15 pages, 1275 KiB  
Article
Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19
by Angelos Liontos, Dimitrios Biros, Rafail Matzaras, Konstantina-Helen Tsarapatsani, Nikolaos-Gavriel Kolios, Athina Zarachi, Konstantinos Tatsis, Christiana Pappa, Maria Nasiou, Eleni Pargana, Ilias Tsiakas, Diamantina Lymperatou, Sempastien Filippas-Ntekouan, Lazaros Athanasiou, Valentini Samanidou, Revekka Konstantopoulou, Ioannis Vagias, Aikaterini Panteli, Haralampos Milionis and Eirini Christaki
Diagnostics 2023, 13(22), 3477; https://doi.org/10.3390/diagnostics13223477 - 19 Nov 2023
Cited by 1 | Viewed by 1329
Abstract
Background: A link between inflammation and venous thromboembolism (VTE) in COVID-19 disease has been suggested pathophysiologically and clinically. The aim of this study was to investigate the association between inflammation and disease outcomes in adult hospitalized COVID-19 patients with VTE. Methods: This was [...] Read more.
Background: A link between inflammation and venous thromboembolism (VTE) in COVID-19 disease has been suggested pathophysiologically and clinically. The aim of this study was to investigate the association between inflammation and disease outcomes in adult hospitalized COVID-19 patients with VTE. Methods: This was a retrospective observational study, including quantitative and qualitative data collected from COVID-19 patients hospitalized at the Infectious Diseases Unit (IDU) of the University Hospital of Ioannina, from 1 March 2020 to 31 May 2022. Venous thromboembolism was defined as a diagnosis of pulmonary embolism (PE) and/or vascular tree-in-bud in the lungs. The burden of disease, assessed by computed tomography of the lungs (CTBoD), was quantified as the percentage (%) of the affected lung parenchyma. The study outcomes were defined as death, intubation, and length of hospital stay (LoS). A chi-squared test and univariate logistic regression analyses were performed in IBM SPSS 28.0. Results: After propensity score matching, the final study cohort included 532 patients. VTE was found in 11.2% of the total population. In patients with VTE, we found that lymphocytopenia and a high neutrophil/lymphocyte ratio were associated with an increased risk of intubation and death, respectively. Similarly, CTBoD > 50% was associated with a higher risk of intubation and death in this group of patients. The triglyceride–glucose (TyG) index was also linked to worse outcomes. Conclusions: Inflammatory indices were associated with VTE. Lymphocytopenia and an increased neutrophil-to-lymphocyte ratio negatively impacted the disease’s prognosis and outcomes. Whether these indices unfavorably affect outcomes in COVID-19-associated VTE must be further evaluated. Full article
(This article belongs to the Special Issue Diagnosis of Viral Respiratory Infections)
Show Figures

Figure 1

Figure 1
<p>Flow diagram of the study.</p>
Full article ">Figure 2
<p>ROC curve of the ML models developed for the outcomes of death (<b>left</b>) and intubation (<b>right</b>).</p>
Full article ">
13 pages, 4448 KiB  
Review
The Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound Connection: Unity Is Strength, or the Endoscopic Ultrasonography Retrograde Cholangiopancreatography Concept
by Claudio Giovanni De Angelis, Eleonora Dall’Amico, Maria Teresa Staiano, Marcantonio Gesualdo, Mauro Bruno, Silvia Gaia, Marco Sacco, Federica Fimiano, Anna Mauriello, Simone Dibitetto, Chiara Canalis, Rosa Claudia Stasio, Alessandro Caneglias, Federica Mediati and Rodolfo Rocca
Diagnostics 2023, 13(20), 3265; https://doi.org/10.3390/diagnostics13203265 - 20 Oct 2023
Cited by 2 | Viewed by 1392
Abstract
Endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) are both crucial for the endoscopic management of biliopancreatic diseases: the combination of their diagnostic and therapeutic potential is useful in many clinical scenarios, such as indeterminate biliary stenosis, biliary stones, chronic pancreatitis and biliary [...] Read more.
Endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) are both crucial for the endoscopic management of biliopancreatic diseases: the combination of their diagnostic and therapeutic potential is useful in many clinical scenarios, such as indeterminate biliary stenosis, biliary stones, chronic pancreatitis and biliary and pancreatic malignancies. This natural and evident convergence between EUS and ERCP, which by 2006 we were calling the “Endoscopic ultrasonography retrograde colangiopancreatography (EURCP) concept”, has become a hot topic in the last years, together with the implementation of the therapeutic possibilities of EUS (from EUS-guided necrosectomy to gastro-entero anastomoses) and with the return of ERCP to its original diagnostic purpose thanks to ancillary techniques (extraductal ultrasound (EDUS), intraductal ultrasound (IDUS), cholangiopancreatoscopy with biopsies and probe-based confocal laser endomicroscopy (pCLE)). In this literary review, we retraced the recent history of EUS and ERCP, reported examples of the clinical applicability of the EURCP concept and explored the option of performing the two procedures in only one endoscopic session, with its positive implications for the patient, the endoscopist and the health care system. In the last few years, we also evaluated the possibility of combining EUS and ERCP into a single endoscopic instrument in a single step, but certain obstacles surrounding this approach remain. Full article
Show Figures

Figure 1

Figure 1
<p>Intraductal ultrasound (IDUS) with 20 MHz probe. (<b>a</b>) Slightly dilated biliary confluence. (<b>b</b>) Dilation of the CBD with sludge. (<b>c</b>) Polypoid intraductal lesion of the CBD (D1: 11 mm; D2: 9 mm). CBD: common bile duct. RHD: right hepatic duct. LHD: left hepatic duct. S: sludge. L: lumen. PL: polypoid lesion.</p>
Full article ">Figure 2
<p>Findings in a malignant biliary stricture during the “all in one technique”. (<b>a</b>) IDUS showing eccentric thickening of the bile duct wall with a polypoid profile (L: lumen; W: bile duct wall; triangle: polypoid-shaped thickening). (<b>b</b>) Cholangioscopic vision of a polypoid lesion of a common bile duct. (<b>c</b>,<b>d</b>) PCLE showing some features of malignancy according to the Miami classification for biliary stenosis (thick dark and white bands and dark clumps).</p>
Full article ">Figure 3
<p>Deployment of LAMS into a dilated common bile duct (CBD) to perform EUS-guided biliary drainage. (<b>a</b>) Cystotome of LAMS (white arrow) conducted into the CBD (star) under EUS-guide; triangle: cystic duct. (<b>b</b>) EUS view of the opening of the distal flange of LAMS (yellow arrow) into the CBD (star). (<b>c</b>) Luminal view of proximal flange opened with bile outflow.</p>
Full article ">Figure 4
<p>On the left is a standard ERCP scope; on the right is an operative EUS scope; and in the middle, is the “ERCP-FNA” or “EURCP” scope.</p>
Full article ">
Back to TopTop